Cefdinir Powder, For Suspension
Product Images NDC 71205-380

2 FDA label images from Proficient Rx Lp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cefdinir (NDC 71205-380). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cefdinir (9c257a43 11dd 483c B020 E2db17f32a99 01)

Cefdinir (9c257a43 11dd 483c B020 E2db17f32a99 01)
Chemical structure of cefdinir, showing its molecular framework with thiazole and beta-lactam rings, amide and carboxyl functional groups.*
FDA Label Image

71205-380-60 (9c257a43 11dd 483c B020 E2db17f32a99 03)

71205-380-60 (9c257a43 11dd 483c B020 E2db17f32a99 03)
Cefdinir 250 mg/5 mL oral suspension powder label from Proficient Rx LP. The 60 mL bottle label displays product strength, form, and manufacturer Lupin Limited with storage instructions (20°-25°C). The label includes dosing information for 5 mL containing 250 mg cefdinir and cautions for oral use only with shaking before use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.